Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Synergy effect of the appetite hormone GLP-1 (LiragluTide) and Exercise on maintenance of weight loss and health after a low calorie diet - the S-LiTE randomized trial

Next Previous
Trial Profile

Synergy effect of the appetite hormone GLP-1 (LiragluTide) and Exercise on maintenance of weight loss and health after a low calorie diet - the S-LiTE randomized trial

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Nov 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Acronyms S-LiTE

    • Most Recent Events

    • 06 Oct 2023 Results assessing to investigate changes in bone health during a diet-induced weight loss followed by a one-year weight maintenance intervention with liraglutide, exercise, or the combination of both compared with a placebo group presented at the 59th Annual Meeting of the European Association for the Study of Diabetes
    • 06 Oct 2023 Results assessing LEAP2 levels after diet-induced weight loss and following one year of treatment with exercise, the GLP-1 receptor agonist liraglutide, or a combination of exercise and liraglutide presented at the 59th Annual Meeting of the European Association for the Study of Diabetes
    • 30 Jun 2022 Results of sub-study of this study assessing long-term effects of weight loss on semen parameters in 56 men, published in the Human Reproduction.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top